Literature DB >> 3740622

Turbinate atrophy in gnotobiotic pigs intranasally inoculated with protein toxin isolated from type D Pasteurella multocida.

M A Dominick, R B Rimler.   

Abstract

Three doses (75 micrograms, 25 micrograms, and 25 micrograms) of purified toxin isolated from a toxigenic strain of type D Pasteurella multocida were given (by atomizer) into the right nasal cavities of each of 10 gnotobiotic pigs on the 21st, 24th, and 27th days of age, respectively. Inoculated pigs (usually 2) and 1 noninoculated control pig each were necropsied on 3, 6, 9, 12, and 15 days after inoculations were given. Severe bilateral atrophy of turbinates occurred in all toxin challenge-exposed pigs. Atrophy was more severe in the inoculated nasal cavity than that in the noninoculated side in 2 of the 10 pigs. Microscopic changes in turbinates of toxin challenge-exposed pigs were more severe in pigs killed at later dates. Dominant changes included degeneration and necrosis of osteoblasts, markedly accelerated osteoclastic osteolysis, replacement of the osseous core by a highly cellular mesenchymal stroma, and multifocal atrophy of submucosal glands. Seemingly, a protein toxin isolated from toxigenic type D strains of P multocida produced rapid atrophy of turbinates and may be a contributing factor in development of clinical progressive atrophic rhinitis in swine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3740622

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  15 in total

1.  Association of Pasteurella multocida toxin with vimentin.

Authors:  Hiroaki Shime; Takahiro Ohnishi; Kaori Nagao; Kiyomasa Oka; Toshifumi Takao; Yasuhiko Horiguchi
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Effect of Pasteurella multocida toxin on bone resorption in vitro.

Authors:  R Felix; H Fleisch; P L Frandsen
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

3.  Crystallization and preliminary crystallographic studies of the Pasteurella multocida toxin catalytic domain.

Authors:  Masayuki Miyazawa; Kengo Kitadokoro; Shigeki Kamitani; Hiroaki Shime; Yasuhiko Horiguchi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-18

4.  Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures.

Authors:  I Jutras; B Martineau-Doizé
Journal:  Can J Vet Res       Date:  1996-01       Impact factor: 1.310

5.  Development of turbinate lesions and nasal colonization by Bordetella bronchiseptica and Pasteurella multocida during long-term exposure of healthy pigs to pigs affected by atrophic rhinitis.

Authors:  L R Bäckström; T A Brim; M T Collins
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

6.  Stimulation of bone resorption by inflamed nasal mucosa, dermonecrotic toxin-containing conditioned medium from Pasteurella multocida, and purified dermonecrotic toxin from P. multocida.

Authors:  T G Kimman; C W Löwik; L J van de Wee-Pals; C W Thesingh; P Defize; E M Kamp; O L Bijvoet
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Pasteurella multocida and Bordetella bronchiseptica infections in rabbits.

Authors:  B J Deeb; R F DiGiacomo; B L Bernard; S M Silbernagel
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

8.  Detection and enumeration of toxin-producing Pasteurella multocida with a colony-blot assay.

Authors:  T Magyar; R B Rimler
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  Atrophic rhinitis caused by Pasteurella multocida type D: morphometric analysis.

Authors:  B Martineau-Doizé; G Dumas; R Larochelle; J C Frantz; G P Martineau
Journal:  Can J Vet Res       Date:  1991-07       Impact factor: 1.310

Review 10.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.